Back to Search
KAREN RICKERT, DO
DO
Family Medicine Physician
NPI: 1699737353Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
104068(MT)
Research & Publications (20)
Development of thioquinazolinones, allosteric Chk1 kinase inhibitors.
PMID 19155174·Bioorg Med Chem Lett·2009
8-other
Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor.
PMID 18951929·Neurosci Res·2009
7-preclinical
Structure of human prostasin, a target for the regulation of hypertension.
PMID 18922802·J Biol Chem·2008
8-other
Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP.
PMID 17999913·Arch Biochem Biophys·2008
8-other
Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSP.
PMID 17761419·Bioorg Med Chem Lett·2007
8-other
Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase.
PMID 17900896·Bioorg Med Chem Lett·2007
8-other
Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP.
PMID 17804233·Bioorg Med Chem Lett·2007
7-preclinical
Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors.
PMID 17804227·Bioorg Med Chem Lett·2007
8-other
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase.
PMID 16368234·Bioorg Med Chem Lett·2006
7-preclinical
Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitors.
PMID 16990002·Bioorg Med Chem Lett·2006
7-preclinical
3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6.
PMID 16978863·Bioorg Med Chem Lett·2006
8-other
Alternative medicine and the duty to employ ordinary means.
PMID 16425500·Natl Cathol Bioeth Q·2005
8-other
Effect of image uncertainty on the dosimetry of trigeminal neuralgia irradiation.
PMID 16029818·Int J Radiat Oncol Biol Phys·2005
8-other
Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator.
PMID 15670368·Neurosurgery·2005
3-trial
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel.
PMID 15566305·J Med Chem·2004
7-preclinical
Analysis of the activating mutations within the activation loop of leukemia targets Flt-3 and c-Kit based on protein homology modeling.
PMID 15363457·J Mol Graph Model·2004
4-observational
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase.
PMID 15125964·Bioorg Med Chem Lett·2004
8-other
Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR.
PMID 15012992·Bioorg Med Chem Lett·2004
8-other
A novel orally bioavailable inhibitor of kinase insert domain-containing receptor induces antiangiogenic effects and prevents tumor growth in vivo.
PMID 14744794·Cancer Res·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3933 ASHLEY LAKE RD
KALISPELL, MT 59901 - Phone
- (440) 915-6235
Quick Facts
- NPI
- 1699737353
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile